Just as proposed for diabetic cardiomyopathy, the myocardial alterations associated with obesity are likely to be a result of several similar synergistically acting mechanisms [8], and it is possible that low insulin sensitivity, as previously suggested for fasting plasma glucose [20], primarily acts as an effect modifier of these other risk factors. This evidence concerns the gene INS and Obesity.